[4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-[7-FLUORO-1-(2-METHOXY-ETHYL)-4-TRIFLUOROMETHOXY-1H-INDOL-3-YL]-METHANONE AS AN INHIBITOR OF MAST CELL TRYPTASE
申请人:CHOI-SLEDESKI Yong Mi
公开号:US20110201647A1
公开(公告)日:2011-08-18
The present invention is directed to an indole benzylamine compound of formula I:
useful as an inhibitor of tryptase. In addition, the present invention is directed to the use of the compound for treating a patient suffering from, or subject to, a physiological condition in need of amelioration by inhibition of tryptase, comprising administering to the patient of a therapeutically effective amount of the compound, and to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier.
本发明涉及一种式为I的吲哚苄胺化合物:用作抑制组胺酶的药物。此外,本发明还涉及使用该化合物治疗患有或受到需要通过抑制组胺酶改善生理状况的患者,包括向患者施用该化合物的治疗有效量,以及包括式I化合物的药物组合物,其中该化合物的药物有效量和药物可接受载体。